首页 > 最新文献

Internal Medicine最新文献

英文 中文
Successful Treatment with Ramucirumab Plus Erlotinib following Osimertinib-induced Interstitial Lung Disease. 奥希替尼诱发间质性肺病后,Ramucirumab 联合厄洛替尼治疗成功:病例报告。
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-03-01 Epub Date: 2024-07-25 DOI: 10.2169/internalmedicine.3932-24
Shodai Fujimoto, Naoko Katsurada, Daisuke Hazama, Masatsugu Yamamoto, Tatusya Nagano, Motoko Tachihara

Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) are key drugs for patients with EGFR mutation-positive non-small cell lung cancer, and osimertinib is the standard treatment. Although drug-induced interstitial lung disease (ILD) is a remarkable adverse event of EGFR-TKIs, evidence regarding the continuation and re-challenge of EGFR-TKIs after drug-induced severe ILD is lacking. This is the first report of successful switching to ramucirumab plus erlotinib after osimertinib-induced severe ILD in an 81-year-old woman with stage IV lung adenocarcinoma harboring the EGFR L858R mutation in exon 21. These findings suggest that ramucirumab plus erlotinib may be a viable treatment option for osimertinib-induced severe ILD.

表皮生长因子受体(EGFR)-酪氨酸激酶抑制剂(TKIs)是治疗表皮生长因子受体突变阳性非小细胞肺癌患者的主要药物,奥希替尼是标准治疗药物。尽管药物诱发的间质性肺病(ILD)是表皮生长因子受体抑制剂(EGFR-TKIs)的一个显著不良反应,但目前尚缺乏有关药物诱发严重ILD后继续使用和再次挑战EGFR-TKIs的证据。本文首次报道了一名81岁的肺腺癌IV期女性患者,在奥希替尼诱发严重ILD后,成功转用拉穆单抗加厄洛替尼治疗,该患者的外显子21中携带EGFR L858R突变。这些研究结果表明,ramucirumab联合厄洛替尼可能是治疗奥希替尼诱发的严重ILD的一种可行方案。
{"title":"Successful Treatment with Ramucirumab Plus Erlotinib following Osimertinib-induced Interstitial Lung Disease.","authors":"Shodai Fujimoto, Naoko Katsurada, Daisuke Hazama, Masatsugu Yamamoto, Tatusya Nagano, Motoko Tachihara","doi":"10.2169/internalmedicine.3932-24","DOIUrl":"10.2169/internalmedicine.3932-24","url":null,"abstract":"<p><p>Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) are key drugs for patients with EGFR mutation-positive non-small cell lung cancer, and osimertinib is the standard treatment. Although drug-induced interstitial lung disease (ILD) is a remarkable adverse event of EGFR-TKIs, evidence regarding the continuation and re-challenge of EGFR-TKIs after drug-induced severe ILD is lacking. This is the first report of successful switching to ramucirumab plus erlotinib after osimertinib-induced severe ILD in an 81-year-old woman with stage IV lung adenocarcinoma harboring the EGFR L858R mutation in exon 21. These findings suggest that ramucirumab plus erlotinib may be a viable treatment option for osimertinib-induced severe ILD.</p>","PeriodicalId":13719,"journal":{"name":"Internal Medicine","volume":" ","pages":"749-751"},"PeriodicalIF":1.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141758563","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Precision Trigger Point Injections: An Anatomically Guided Approach for Anterior Cutaneous Nerve Entrapment Syndrome Treatment. 精确触发点注射:以解剖学为指导的前皮肤神经卡压综合征治疗方法。
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-03-01 Epub Date: 2024-08-01 DOI: 10.2169/internalmedicine.3979-24
Takashi Watari, Yuki Otsuka, Yoshihiko Shiraishi
{"title":"Precision Trigger Point Injections: An Anatomically Guided Approach for Anterior Cutaneous Nerve Entrapment Syndrome Treatment.","authors":"Takashi Watari, Yuki Otsuka, Yoshihiko Shiraishi","doi":"10.2169/internalmedicine.3979-24","DOIUrl":"10.2169/internalmedicine.3979-24","url":null,"abstract":"","PeriodicalId":13719,"journal":{"name":"Internal Medicine","volume":" ","pages":"805"},"PeriodicalIF":1.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141859660","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thromboembolism and Bleeding in the Triangle of STEMI, Cancer and Atrial Fibrillation. STEMI、癌症和心房颤动三角区的血栓栓塞和出血。
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-03-01 Epub Date: 2024-08-01 DOI: 10.2169/internalmedicine.4293-24
Yusuf Ziya Şener
{"title":"Thromboembolism and Bleeding in the Triangle of STEMI, Cancer and Atrial Fibrillation.","authors":"Yusuf Ziya Şener","doi":"10.2169/internalmedicine.4293-24","DOIUrl":"10.2169/internalmedicine.4293-24","url":null,"abstract":"","PeriodicalId":13719,"journal":{"name":"Internal Medicine","volume":" ","pages":"803"},"PeriodicalIF":1.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141859664","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinicopathological Features of Methotrexate-associated Lymphoproliferative Disorders in the Gastrointestinal Tract. 甲氨蝶呤相关胃肠道淋巴组织增生性疾病的临床病理特征
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-03-01 Epub Date: 2024-07-25 DOI: 10.2169/internalmedicine.3719-24
Takeya Edagawa, Hiroyoshi Iwagami, Takuji Akamatsu, Shogo Nakano, Midori Wakita, Takafumi Konishi, Yasuki Nakatani, Yoshito Uenoyama, Yukitaka Yamashita

Methotrexate may cause methotrexate-associated lymphoproliferative disorder (MTX-LPD); however, this disease is uncommon in the gastrointestinal tract. We examined six patients with MTX-LPD in the gastrointestinal tract at our hospital. All of the lesions were ulcerative. Four cases regressed spontaneously, all of which were positive for Epstein-Barr virus-encoded small RNA by in situ hybridization. Two patients who did not regress were negative for Epstein-Barr virus RNA, one of whom received chemotherapy, and one underwent surgery. The prognosis of this disease is considered to be good. MTX-LPD should considered when ulcerative lesions are observed during endoscopy in patients receiving MTX.

甲氨蝶呤可能导致甲氨蝶呤相关淋巴组织增生性疾病(MTX-LPD),但这种疾病在胃肠道并不常见。我们对本院六名胃肠道 MTX-LPD 患者进行了检查。所有病变均为溃疡性。其中四例患者的病灶自行消退,通过原位杂交检测,所有病灶的 Epstein-Barr 病毒编码的小 RNA 均呈阳性。有两名患者的爱泼斯坦-巴氏病毒 RNA 呈阴性,其中一人接受了化疗,一人接受了手术。该病预后良好。当接受MTX治疗的患者在内镜检查中发现溃疡性病变时,应考虑MTX-LPD。
{"title":"Clinicopathological Features of Methotrexate-associated Lymphoproliferative Disorders in the Gastrointestinal Tract.","authors":"Takeya Edagawa, Hiroyoshi Iwagami, Takuji Akamatsu, Shogo Nakano, Midori Wakita, Takafumi Konishi, Yasuki Nakatani, Yoshito Uenoyama, Yukitaka Yamashita","doi":"10.2169/internalmedicine.3719-24","DOIUrl":"10.2169/internalmedicine.3719-24","url":null,"abstract":"<p><p>Methotrexate may cause methotrexate-associated lymphoproliferative disorder (MTX-LPD); however, this disease is uncommon in the gastrointestinal tract. We examined six patients with MTX-LPD in the gastrointestinal tract at our hospital. All of the lesions were ulcerative. Four cases regressed spontaneously, all of which were positive for Epstein-Barr virus-encoded small RNA by in situ hybridization. Two patients who did not regress were negative for Epstein-Barr virus RNA, one of whom received chemotherapy, and one underwent surgery. The prognosis of this disease is considered to be good. MTX-LPD should considered when ulcerative lesions are observed during endoscopy in patients receiving MTX.</p>","PeriodicalId":13719,"journal":{"name":"Internal Medicine","volume":" ","pages":"687-693"},"PeriodicalIF":1.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141758558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recurrent Positional Vomiting due to Cerebellar Infarction and Obstructive Hydrocephalus: A Case Report. 小脑梗塞和阻塞性脑积水导致的复发性体位性呕吐:病例报告。
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-03-01 DOI: 10.2169/internalmedicine.5080-24
Gohei Yamada

An 80-year-old woman presented with the sudden onset of vertigo and vomiting and was diagnosed with acute cerebellar infarction. Twelve days after the onset, she experienced positional vomiting, predominantly in the lying-down position, triggered by postural changes with immediate or delayed onset. Over 1 month, 23 episodes of vomiting occurred. Brain computed tomography revealed edema in the infarcted area, fourth ventricular outlet compression, and lateral ventricular enlargement. These findings suggest that fluctuations in intracranial pressure are associated with intermittent obstructive hydrocephalus exacerbated by the patient's posture. This case highlights the importance of considering postural triggers in patients with recurrent vomiting associated with cerebellar infarctions.

{"title":"Recurrent Positional Vomiting due to Cerebellar Infarction and Obstructive Hydrocephalus: A Case Report.","authors":"Gohei Yamada","doi":"10.2169/internalmedicine.5080-24","DOIUrl":"https://doi.org/10.2169/internalmedicine.5080-24","url":null,"abstract":"<p><p>An 80-year-old woman presented with the sudden onset of vertigo and vomiting and was diagnosed with acute cerebellar infarction. Twelve days after the onset, she experienced positional vomiting, predominantly in the lying-down position, triggered by postural changes with immediate or delayed onset. Over 1 month, 23 episodes of vomiting occurred. Brain computed tomography revealed edema in the infarcted area, fourth ventricular outlet compression, and lateral ventricular enlargement. These findings suggest that fluctuations in intracranial pressure are associated with intermittent obstructive hydrocephalus exacerbated by the patient's posture. This case highlights the importance of considering postural triggers in patients with recurrent vomiting associated with cerebellar infarctions.</p>","PeriodicalId":13719,"journal":{"name":"Internal Medicine","volume":" ","pages":""},"PeriodicalIF":1.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143537051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Necrotizing Fasciitis Due to Group A Streptococcus: A Case of a Deteriorating Biphasic-like Clinical Course over Five Days with a Devastating Outcome. A 群链球菌引起的坏死性筋膜炎:一例临床症状在五天内呈双相型恶化并导致严重后果的病例。
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-03-01 Epub Date: 2024-07-11 DOI: 10.2169/internalmedicine.4021-24
Kenya Toma, Haruka Ishiki, Yusuke Oshiro, Takashi Shinzato, Yasuharu Tokuda

Necrotizing fasciitis (NF) is a life-threatening disease with high mortality and rapidly progressive clinical manifestations. Early detection and surgical management coupled with antibiotic treatment are crucial for the survival, and the patient survival is heavily dependent on clinical decisions. However, it is not widely known that NF does not always follow a typical clinical course, and there have been no case reports of NF following an atypical clinical course. Although the course of the disease depends on the individual patient, it remains a challenge for physicians to determine the precise timing when patients are most likely to survive multiple surgical interventions. We encountered a challenging case presenting with an atypical clinical course. We herein report a 31 year-old man who followed a deteriorating biphasic-like clinical course and presented with extensive NF and streptococcal toxic shock syndrome due to Group A Streptococcus. This case serves to inform physicians of the existence of NF with an atypical and deteriorating biphasic-like clinical course, emphasizing the need for a careful evaluation of the patient condition.

坏死性筋膜炎(NF)是一种危及生命的疾病,死亡率高,临床表现进展迅速1。早期发现、手术治疗和抗生素治疗对患者的存活至关重要,而患者的存活在很大程度上取决于临床决定2,3。然而,NF 并不总是遵循典型的临床病程,这一点并不广为人知,目前还没有关于 NF 非典型临床病程的病例报告。虽然病程因患者个体而异,但如何确定患者在多次手术干预后最有可能存活的确切时间,对医生来说仍是一项挑战。我们遇到了一个临床病程不典型的挑战性病例。我们在此报告了一名 31 岁的男性患者,他的临床病程呈双相型恶化,并伴有广泛的 NF 和 A 组链球菌引起的链球菌中毒性休克综合征。本病例让医生了解到,NF 存在非典型和恶化的双相样临床病程,强调了对患者病情进行仔细评估的必要性。
{"title":"Necrotizing Fasciitis Due to Group A Streptococcus: A Case of a Deteriorating Biphasic-like Clinical Course over Five Days with a Devastating Outcome.","authors":"Kenya Toma, Haruka Ishiki, Yusuke Oshiro, Takashi Shinzato, Yasuharu Tokuda","doi":"10.2169/internalmedicine.4021-24","DOIUrl":"10.2169/internalmedicine.4021-24","url":null,"abstract":"<p><p>Necrotizing fasciitis (NF) is a life-threatening disease with high mortality and rapidly progressive clinical manifestations. Early detection and surgical management coupled with antibiotic treatment are crucial for the survival, and the patient survival is heavily dependent on clinical decisions. However, it is not widely known that NF does not always follow a typical clinical course, and there have been no case reports of NF following an atypical clinical course. Although the course of the disease depends on the individual patient, it remains a challenge for physicians to determine the precise timing when patients are most likely to survive multiple surgical interventions. We encountered a challenging case presenting with an atypical clinical course. We herein report a 31 year-old man who followed a deteriorating biphasic-like clinical course and presented with extensive NF and streptococcal toxic shock syndrome due to Group A Streptococcus. This case serves to inform physicians of the existence of NF with an atypical and deteriorating biphasic-like clinical course, emphasizing the need for a careful evaluation of the patient condition.</p>","PeriodicalId":13719,"journal":{"name":"Internal Medicine","volume":" ","pages":"781-785"},"PeriodicalIF":1.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141579577","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Novel De Novo Variant in KCNH5 in a Patient with Refractory Epileptic Encephalopathy. 一名难治性癫痫性脑病患者的 KCNH5 新变异体
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-03-01 Epub Date: 2024-08-01 DOI: 10.2169/internalmedicine.3999-24
Akihiko Mitsutake, Takashi Matsukawa, Tatsuhiko Naito, Hiroyuki Ishiura, Jun Mitsui, Hiroaki Harada, Keishi Fujio, Jun Fujishiro, Harushi Mori, Shinichi Morishita, Shoji Tsuji, Tatsushi Toda

We herein report a novel de novo KCNH5 variant in a patient with refractory epileptic encephalopathy. The patient exhibited seizures at 1 year and 7 months old, which gradually worsened, leading to a bedridden status. Brain magnetic resonance imaging (MRI) showed cerebral atrophy and cerebellar hypoplasia. A trio whole-exome sequence analysis identified a de novo heterozygous c.640A>C, p.Lys214Gln variant in KCNH5 that was predicted to be deleterious. Recent studies have linked KCNH5 to various epileptic encephalopathies, with many patients showing normal MRI findings. The present case expands the clinical spectrum of the disease, as it is characterized by severe neurological prognosis, cerebral atrophy, and cerebellar hypoplasia.

我们在此报告了一名难治性癫痫性脑病患者的新型 KCNH5 基因变异。患者在一岁零七个月时出现癫痫发作,病情逐渐加重,导致卧床不起。脑磁共振成像(MRI)显示患者有脑萎缩和小脑发育不全。三组全外显子组序列分析发现,KCNH5中存在一个新发杂合c.640A>C,p.Lys214Gln变异,预计该变异具有遗传性。最近的研究表明,KCNH5 与多种癫痫性脑病有关,但许多患者的磁共振成像结果显示正常。本病例扩大了该病的临床范围,因为它以严重的神经系统预后、脑萎缩和小脑发育不全为特征。
{"title":"A Novel De Novo Variant in KCNH5 in a Patient with Refractory Epileptic Encephalopathy.","authors":"Akihiko Mitsutake, Takashi Matsukawa, Tatsuhiko Naito, Hiroyuki Ishiura, Jun Mitsui, Hiroaki Harada, Keishi Fujio, Jun Fujishiro, Harushi Mori, Shinichi Morishita, Shoji Tsuji, Tatsushi Toda","doi":"10.2169/internalmedicine.3999-24","DOIUrl":"10.2169/internalmedicine.3999-24","url":null,"abstract":"<p><p>We herein report a novel de novo KCNH5 variant in a patient with refractory epileptic encephalopathy. The patient exhibited seizures at 1 year and 7 months old, which gradually worsened, leading to a bedridden status. Brain magnetic resonance imaging (MRI) showed cerebral atrophy and cerebellar hypoplasia. A trio whole-exome sequence analysis identified a de novo heterozygous c.640A>C, p.Lys214Gln variant in KCNH5 that was predicted to be deleterious. Recent studies have linked KCNH5 to various epileptic encephalopathies, with many patients showing normal MRI findings. The present case expands the clinical spectrum of the disease, as it is characterized by severe neurological prognosis, cerebral atrophy, and cerebellar hypoplasia.</p>","PeriodicalId":13719,"journal":{"name":"Internal Medicine","volume":" ","pages":"759-762"},"PeriodicalIF":1.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141859657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Differences in Lung Cancer-related Clinical Practice and Basic Research Background between Japan and China: A Narrative Review.
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-03-01 DOI: 10.2169/internalmedicine.4808-24
Lan Wang, Yiyan Miao, Yihang Gu, Tomoya Kawaguchi, Megumi Mizutani, Toshiyuki Nakai, Tetsuya Watanabe, Kazuhisa Asai, Hui Zhang, Wenwen Cai, Yoko Tani, Hiroyasu Kaneda

With its increasing incidence, lung cancer has become one of the leading causes of cancer-related deaths worldwide, posing a great threat to the health and lives of patients. Due to varying economic and cultural backgrounds, there are significant differences in clinical treatment practices and related basic research on lung cancer between China and Japan. These differences are mainly reflected in many aspects, such as cancer prevention, cancer treatment, provision of medical insurance, patient compliance, medical education system, and sources of research funding. By understanding these differences, China and Japan can learn from each other, make progress together, and strengthen further exchanges and cooperation, which will help improve the long-term efficacy of lung cancer treatment and improve patients' clinical outcomes.

{"title":"Differences in Lung Cancer-related Clinical Practice and Basic Research Background between Japan and China: A Narrative Review.","authors":"Lan Wang, Yiyan Miao, Yihang Gu, Tomoya Kawaguchi, Megumi Mizutani, Toshiyuki Nakai, Tetsuya Watanabe, Kazuhisa Asai, Hui Zhang, Wenwen Cai, Yoko Tani, Hiroyasu Kaneda","doi":"10.2169/internalmedicine.4808-24","DOIUrl":"https://doi.org/10.2169/internalmedicine.4808-24","url":null,"abstract":"<p><p>With its increasing incidence, lung cancer has become one of the leading causes of cancer-related deaths worldwide, posing a great threat to the health and lives of patients. Due to varying economic and cultural backgrounds, there are significant differences in clinical treatment practices and related basic research on lung cancer between China and Japan. These differences are mainly reflected in many aspects, such as cancer prevention, cancer treatment, provision of medical insurance, patient compliance, medical education system, and sources of research funding. By understanding these differences, China and Japan can learn from each other, make progress together, and strengthen further exchanges and cooperation, which will help improve the long-term efficacy of lung cancer treatment and improve patients' clinical outcomes.</p>","PeriodicalId":13719,"journal":{"name":"Internal Medicine","volume":" ","pages":""},"PeriodicalIF":1.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143537021","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pulmonary Arterial Hypertension in Neurofibromatosis Type 1: A Case with a Novel NF1 Gene Mutation. 神经纤维瘤病 1 型肺动脉高压:一例新型 NF1 基因突变病例
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-03-01 Epub Date: 2024-07-11 DOI: 10.2169/internalmedicine.3856-24
Shusuke Yagi, Muneyuki Kadota, Ryo Bando, Ryosuke Miyamoto, Hiroyuki Morino, Akiyoshi Kakutani, Yoshiaki Kubo, Takayuki Ise, Rie Ueno, Tomoya Hara, Kenya Kusunose, Koji Yamaguchi, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Daiju Fukuda, Masataka Sata

Neurofibromatosis type 1 (NF1) is an autosomal dominant multi-organ disease. The clinical manifestations include not only skin lesions and malignant tumors but also lung complications, including pulmonary arterial hypertension (PAH). However, the association between gene mutations in NF1 and the occurrence of PAH has not yet been elucidated. We herein report a case of isolated PAH in a 67-year-old woman with NF1, presumably caused by a novel heterozygous mutation, c.4485_4486delinsAT (p.Lys1496Ter), in the NF1 gene.

神经纤维瘤病 1 型(NF1)是一种常染色体显性多器官疾病。其临床表现不仅包括皮肤病变和恶性肿瘤,还包括肺部并发症,包括肺动脉高压(PAH)。然而,NF1 基因突变与 PAH 发生之间的关联尚未阐明。我们在此报告了一例 67 岁女性 NF1 患者的孤立性 PAH 病例,该病例可能是由 NF1 基因中的一个新的杂合突变 c.4485_4486delinsAT (p.Lys1496Ter) 引起的。
{"title":"Pulmonary Arterial Hypertension in Neurofibromatosis Type 1: A Case with a Novel NF1 Gene Mutation.","authors":"Shusuke Yagi, Muneyuki Kadota, Ryo Bando, Ryosuke Miyamoto, Hiroyuki Morino, Akiyoshi Kakutani, Yoshiaki Kubo, Takayuki Ise, Rie Ueno, Tomoya Hara, Kenya Kusunose, Koji Yamaguchi, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Daiju Fukuda, Masataka Sata","doi":"10.2169/internalmedicine.3856-24","DOIUrl":"10.2169/internalmedicine.3856-24","url":null,"abstract":"<p><p>Neurofibromatosis type 1 (NF1) is an autosomal dominant multi-organ disease. The clinical manifestations include not only skin lesions and malignant tumors but also lung complications, including pulmonary arterial hypertension (PAH). However, the association between gene mutations in NF1 and the occurrence of PAH has not yet been elucidated. We herein report a case of isolated PAH in a 67-year-old woman with NF1, presumably caused by a novel heterozygous mutation, c.4485_4486delinsAT (p.Lys1496Ter), in the NF1 gene.</p>","PeriodicalId":13719,"journal":{"name":"Internal Medicine","volume":" ","pages":"725-728"},"PeriodicalIF":1.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141579581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiac Malignant Lymphoma with Diffuse Extension to the Left Ventricle. 心脏恶性淋巴瘤弥漫性扩展至左心室:病例报告。
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-03-01 Epub Date: 2024-07-25 DOI: 10.2169/internalmedicine.3943-24
Daichi Terunuma, Masanobu Miura, Ko Teshima, Yuta Kagaya, Hiroki Saito, Kenjiro Sato, Masanori Kanazawa, Masateru Kondo, Hideaki Endo, Kazunori Murai, Tsutomu Sakuma, Akihiro Nakamura

Malignant cardiac lymphoma is rare and commonly involves nodules on the right side of the heart. We herein report a case of malignant cardiac lymphoma with diffuse extension into the left ventricle. The patient was a woman in her 60s who complained of dyspnea and malaise. Echocardiography revealed left ventricular hypertrophy (LVH), and magnetic resonance imaging revealed diffuse contrast enhancement on delayed contrast. Cardiac catheterization and a myocardial biopsy suggested heart failure due to cardiac malignant lymphoma, and diastolic dysfunction was mild despite LVH. The patient underwent chemotherapy, and her cardiac function improved and was maintained.

恶性心脏淋巴瘤非常罕见,通常累及心脏右侧的结节。我们在此报告一例弥漫性扩展至左心室的恶性心脏淋巴瘤病例。患者是一名 60 多岁的女性,主诉呼吸困难和乏力。超声心动图显示左心室肥厚(LVH),磁共振成像显示延迟造影剂弥漫性对比增强。心导管检查和心肌活检提示心脏恶性淋巴瘤导致心力衰竭,尽管左心室肥厚,但舒张功能障碍轻微。患者接受了化疗,心功能得到了改善和维持。
{"title":"Cardiac Malignant Lymphoma with Diffuse Extension to the Left Ventricle.","authors":"Daichi Terunuma, Masanobu Miura, Ko Teshima, Yuta Kagaya, Hiroki Saito, Kenjiro Sato, Masanori Kanazawa, Masateru Kondo, Hideaki Endo, Kazunori Murai, Tsutomu Sakuma, Akihiro Nakamura","doi":"10.2169/internalmedicine.3943-24","DOIUrl":"10.2169/internalmedicine.3943-24","url":null,"abstract":"<p><p>Malignant cardiac lymphoma is rare and commonly involves nodules on the right side of the heart. We herein report a case of malignant cardiac lymphoma with diffuse extension into the left ventricle. The patient was a woman in her 60s who complained of dyspnea and malaise. Echocardiography revealed left ventricular hypertrophy (LVH), and magnetic resonance imaging revealed diffuse contrast enhancement on delayed contrast. Cardiac catheterization and a myocardial biopsy suggested heart failure due to cardiac malignant lymphoma, and diastolic dysfunction was mild despite LVH. The patient underwent chemotherapy, and her cardiac function improved and was maintained.</p>","PeriodicalId":13719,"journal":{"name":"Internal Medicine","volume":" ","pages":"729-734"},"PeriodicalIF":1.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141758557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Internal Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1